<DOC>
	<DOC>NCT01089543</DOC>
	<brief_summary>The purpose of this study is to assess the efficacy and safety of rabeprazole compared to placebo in Japanese subjects with Functional Dyspepsia.</brief_summary>
	<brief_title>A Study of E3810 for Japanese Subjects With Functional Dyspepsia (SAMURAI Study: Suppression of Acid Milieu With Rabeprazole Improving Functional Dyspepsia ) (Study E3810-J081-204)</brief_title>
	<detailed_description />
	<mesh_term>Dyspepsia</mesh_term>
	<mesh_term>Gastritis</mesh_term>
	<mesh_term>Rabeprazole</mesh_term>
	<criteria>Inclusion criteria: Participants diagnosed as Functional Dyspepsia according to Rome III criteria. Exclusion criteria: Participants with neuropsychiatric disorder. Participants diagnosed with irritable bowel syndrome, inflammatory bowel disease and serious constipation.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>dyspepsia</keyword>
	<keyword>rabeprazole</keyword>
	<keyword>Japan</keyword>
</DOC>